Probably not feasible without some genetic re-engineering to design out vulnerabilities to common diseases. That's how aging will probably be solved. There's a big debug time problem, though. It takes about two generations to be sure you got it right. We'll probably have very long lived mice decades before it works for humans. (Many cancers in mice can be cured now. This doesn't translate to humans.)
Then there will be species conflicts. Merck people won't be able to mate with Novartis people because they'll be too different genetically.